Ghana’s Minister for Health, Hon. Kwabena Mintah-Akandoh, has outlined ambitious steps taken by the government to enhance the country’s immunisation programme and move toward vaccine self-sufficiency.
Speaking at the latest edition of the Government Accountability Series, with conviction, the Minister emphasised the central role of child health in the government’s broader public health strategy and highlighted concrete actions already undertaken to secure a healthier future for Ghana’s next generation.
“The government of Ghana has demonstrated a steadfast commitment to the health and well-being of our children. This year, we increased the budget for the vaccine by 46%.”
Minister for Health, Hon. Kwabena Mintah-Akandoh
This surge in funding reflects the government’s determination to resolve past vaccine shortages that disrupted immunisation schedules and left many children at risk. “As of today, we have fully paid $24.5 million to GAVIi,” he announced, calling it a critical milestone.
According to the Minister, this timely payment not only cements Ghana’s credibility with international partners but also helps the country avert the recurring shortages of essential vaccines that have, in recent years, contributed to preventable disease outbreaks.
Hon. Mintah-Akandoh confirmed that hundreds of thousands of vaccine doses are set to arrive in the country by August 2025, with distribution planned to reach all corners of the nation.
He underscored the strategic importance of equitable distribution, reaffirming the government’s dedication to ensuring no child is left unprotected, regardless of where they live.
“We are not resting on our achievements. The government will continue to prioritise and invest in immunisation to protect every child and build a healthier nation for generations to come.”
Minister for Health, Hon. Kwabena Mintah-Akandoh
Ghana to Become Vaccine Hub
Beyond immediate immunisation goals, the Minister also discussed long-term plans to establish Ghana as a hub for vaccine manufacturing in Africa.
He revealed that the National Vaccine Institute is working closely with regulatory bodies and pharmaceutical industry players to build the necessary infrastructure and capacity.
“The government has pledged and is dedicated to making Ghana a center for vaccine manufacturing,” he said. In a tangible step towards this vision, Hon. Mintah-Akandoh announced a significant breakthrough in local pharmaceutical production.
“I’m happy to inform you that one of our private sector partners has obtained market authorisation from Ghana’s FDA to produce snake anti-venom serum on a commercial scale”.
Minister for Health, Hon. Kwabena Mintah-Akandoh
This move, he added, marks a shift from Ghana being merely a consumer of medical products to becoming a producer, capable of supplying both domestic and potentially regional needs.
The announcement is especially timely, given the persistent challenges rural communities face with snakebite treatment and the reliance on expensive imported antivenoms.
Commercial-scale production of the serum in Ghana could drastically improve availability and affordability, ultimately saving lives in the most vulnerable areas.
The Minister’s address underscores a broader narrative of health sector transformation underpinned by proactive policy, international collaboration, and a growing role for the domestic private sector.
His emphasis on moving from reactive procurement to sustainable vaccine production aligns with global health security goals and positions Ghana as an emerging leader in African pharmaceutical innovation.
While the road ahead may present technical and logistical hurdles, the Health Minister’s confidence suggests a government that sees vaccine sovereignty not just as a health imperative, but as a strategic investment in national development.
READ ALSO: Trade Surplus Hits $5.6 Billion as Ghana’s External Sector Flexes Muscle Ahead of July MPC Decision
